https://orcid.org/0000-0003-3532-5238
References
- Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants, 2016
- Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American heart association task force on practice guidelines and the obesity society. Circulation. 2014 Jun 24;129(25 Suppl 2):S102–38.
- Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011 Jul;34(7):1481–1486. .
- Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014 Jan 1;311(1):74–86.
- Makaryus JN, Makaryus AN. Cardiac arrest in the setting of diet pill consumption. Am J Emerg Med. 2008 Jul;26(6):732.e1-3.
- Ulus IH, Maher TJ, Wurtman RJ. Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors. Biochem Pharmacol. 2000 Jun 15;59(12):1611–1621.
- Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med. 2000 Dec;173(6):412–415.
- Ling LH, Marchant C, Buckley NA, et al. Poisoning with the recreational drug paramethoxyamphetamine (“death”). Med J Aust. 2001 May 7;174(9):453–455.
- Tobbia P, Norris LA, Klima LD. Ventricular fibrillation coinciding with phentermine initiation. BMJ Case Rep. 2012 Oct 12;2012:bcr2012006410. .
- Hung YM, Chang JC. Weight-reducing regimen associated with polymorphic ventricular tachycardia. Am J Emerg Med. 2006 Oct;24(6):714–716.
- Hung MJ, Kuo LT, Cherng WJ. Amphetamine-related acute myocardial infarction due to coronary artery spasm. Int J Clin Pract. 2003 Jan-Feb;57(1):62–64.
- El Menyar AA. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med. 2006 Jan-Mar;52(1):51–56.
- Tantrachoti P, Klomjit S, Rassameehiran S, et al. Supraventricular tachycardia associated with phentermine use. Chronicles [Internet]. 2016 Jul 14; 4(15):70–74. .
- Keppel S. An unlikely cause of atrial fibrillation-induced cardiomyopathy: phentermine, a diet pill. Int J Clin Cardiol. 2015;2(2). DOI:10.23937/2378-2951/1410029.
- Patel PJ, Segar R, Patel JK, et al. Arrhythmia induction using isoproterenol or epinephrine during electrophysiology study for supraventricular tachycardia. J Cardiovasc Electrophysiol. 2018 12;29(12):1635–1640. .
- Jordan J, Astrup A, Engeli S, et al. Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. J Hypertens. 2014 Jun;32(6):1178–1188.
- He SY, Matoba R, Fujitani N, et al. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol. 1996 Jun;17(2):155–162.
- Kheirkhahan M, Azadani P, Marrouche N. P1618Left atrial (LA) fibrosis: a predictor for supraventricular tachycardia. EP Europace. 2017;19(suppl_3):iii347–iii347.
- Romero J, Kumar S, Akira F, et al. Emergence of atrioventricular nodal reentry tachycardia after surgical or catheter ablation for atrial fibrillation: are we creating the arrhythmia substrate? Heart Rhythm. 2017 Nov;14(11):1637–1646. . Epub 2017 Aug 8. PMID: 28797677
- Casis O, Espiña L, Gallego M. Effects of amphetamine on calcium and potassium currents in rat heart. J Cardiovasc Pharmacol. 2000 Sep;36(3):390–395.
- Brugada J, Katritsis DG, Arbelo E, et al., ESC Scientific Document Group. 2019 ESC guidelines for the management of patients with supraventricular tachycardiaThe task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655–720. . PMID: 31504425.